| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | axon guidance | 1.33e-05 | 285 | 23 | 5 | GO:0007411 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 1.36e-05 | 286 | 23 | 5 | GO:0097485 | |
| GeneOntologyBiologicalProcess | axonogenesis | 2.82e-05 | 566 | 23 | 6 | GO:0007409 | |
| GeneOntologyBiologicalProcess | axon development | 5.70e-05 | 642 | 23 | 6 | GO:0061564 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | 1.33e-04 | 748 | 23 | 6 | GO:0048667 | |
| GeneOntologyBiologicalProcess | somatic stem cell division | 1.60e-04 | 17 | 23 | 2 | GO:0048103 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | 1.94e-04 | 802 | 23 | 6 | GO:0048812 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | 2.17e-04 | 819 | 23 | 6 | GO:0120039 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | 2.28e-04 | 826 | 23 | 6 | GO:0048858 | |
| GeneOntologyBiologicalProcess | regulation of cell-cell adhesion mediated by cadherin | 2.47e-04 | 21 | 23 | 2 | GO:2000047 | |
| GeneOntologyBiologicalProcess | regulation of endothelial cell chemotaxis | 3.80e-04 | 26 | 23 | 2 | GO:2001026 | |
| GeneOntologyBiologicalProcess | blood vessel development | 4.29e-04 | 929 | 23 | 6 | GO:0001568 | |
| GeneOntologyBiologicalProcess | glomerulus vasculature development | 5.08e-04 | 30 | 23 | 2 | GO:0072012 | |
| GeneOntologyBiologicalProcess | vasculature development | 5.37e-04 | 969 | 23 | 6 | GO:0001944 | |
| GeneOntologyBiologicalProcess | kidney vasculature development | 5.42e-04 | 31 | 23 | 2 | GO:0061440 | |
| GeneOntologyBiologicalProcess | renal system vasculature development | 5.42e-04 | 31 | 23 | 2 | GO:0061437 | |
| GeneOntologyBiologicalProcess | endothelial cell chemotaxis | 6.92e-04 | 35 | 23 | 2 | GO:0035767 | |
| GeneOntologyBiologicalProcess | embryonic hindlimb morphogenesis | 6.92e-04 | 35 | 23 | 2 | GO:0035116 | |
| GeneOntologyBiologicalProcess | skin development | 7.10e-04 | 373 | 23 | 4 | GO:0043588 | |
| GeneOntologyBiologicalProcess | circulatory system development | 7.28e-04 | 1442 | 23 | 7 | GO:0072359 | |
| GeneOntologyBiologicalProcess | negative regulation of neurogenesis | 9.08e-04 | 173 | 23 | 3 | GO:0050768 | |
| GeneOntologyBiologicalProcess | negative regulation of nervous system development | 1.08e-03 | 184 | 23 | 3 | GO:0051961 | |
| GeneOntologyBiologicalProcess | positive regulation of nervous system development | 1.08e-03 | 418 | 23 | 4 | GO:0051962 | |
| GeneOntologyBiologicalProcess | positive regulation of neuroblast proliferation | 1.09e-03 | 44 | 23 | 2 | GO:0002052 | |
| GeneOntologyBiologicalProcess | appendage morphogenesis | 1.10e-03 | 185 | 23 | 3 | GO:0035107 | |
| GeneOntologyBiologicalProcess | limb morphogenesis | 1.10e-03 | 185 | 23 | 3 | GO:0035108 | |
| GeneOntologyBiologicalProcess | keratinocyte differentiation | 1.17e-03 | 189 | 23 | 3 | GO:0030216 | |
| GeneOntologyBiologicalProcess | hindlimb morphogenesis | 1.35e-03 | 49 | 23 | 2 | GO:0035137 | |
| GeneOntologyBiologicalProcess | stem cell division | 1.35e-03 | 49 | 23 | 2 | GO:0017145 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion mediated by cadherin | 1.41e-03 | 50 | 23 | 2 | GO:0044331 | |
| GeneOntologyCellularComponent | Golgi lumen | 3.29e-04 | 109 | 26 | 3 | GO:0005796 | |
| HumanPheno | Perifollicular hyperkeratosis | 2.08e-05 | 4 | 10 | 2 | HP:0007468 | |
| HumanPheno | Abnormal perifollicular morphology | 5.18e-05 | 6 | 10 | 2 | HP:0031285 | |
| HumanPheno | Abnormal enzyme activity in muscle tissue | 9.65e-05 | 8 | 10 | 2 | HP:0034526 | |
| Domain | EGF-like_dom | 9.73e-07 | 249 | 26 | 6 | IPR000742 | |
| Domain | DUF3454 | 5.59e-06 | 3 | 26 | 2 | PF11936 | |
| Domain | DUF3454_notch | 5.59e-06 | 3 | 26 | 2 | IPR024600 | |
| Domain | DUF3454 | 5.59e-06 | 3 | 26 | 2 | SM01334 | |
| Domain | NOD | 1.12e-05 | 4 | 26 | 2 | PF06816 | |
| Domain | Notch | 1.12e-05 | 4 | 26 | 2 | IPR008297 | |
| Domain | NODP | 1.12e-05 | 4 | 26 | 2 | PF07684 | |
| Domain | Notch_NODP_dom | 1.12e-05 | 4 | 26 | 2 | IPR011656 | |
| Domain | Notch_NOD_dom | 1.12e-05 | 4 | 26 | 2 | IPR010660 | |
| Domain | NOD | 1.12e-05 | 4 | 26 | 2 | SM01338 | |
| Domain | NODP | 1.12e-05 | 4 | 26 | 2 | SM01339 | |
| Domain | EGF_3 | 1.60e-05 | 235 | 26 | 5 | PS50026 | |
| Domain | LNR | 1.86e-05 | 5 | 26 | 2 | PS50258 | |
| Domain | EGF_1 | 2.37e-05 | 255 | 26 | 5 | PS00022 | |
| Domain | EGF-like_CS | 2.65e-05 | 261 | 26 | 5 | IPR013032 | |
| Domain | EGF_2 | 2.85e-05 | 265 | 26 | 5 | PS01186 | |
| Domain | Notch_dom | 3.90e-05 | 7 | 26 | 2 | IPR000800 | |
| Domain | Notch | 3.90e-05 | 7 | 26 | 2 | PF00066 | |
| Domain | NL | 3.90e-05 | 7 | 26 | 2 | SM00004 | |
| Domain | EGF_extracell | 7.77e-05 | 60 | 26 | 3 | IPR013111 | |
| Domain | EGF_2 | 7.77e-05 | 60 | 26 | 3 | PF07974 | |
| Domain | Disintegrin_CS | 2.21e-04 | 16 | 26 | 2 | IPR018358 | |
| Domain | ADAM_CR | 2.81e-04 | 18 | 26 | 2 | PF08516 | |
| Domain | EGF | 2.94e-04 | 235 | 26 | 4 | SM00181 | |
| Domain | EGF_Ca-bd_CS | 3.24e-04 | 97 | 26 | 3 | IPR018097 | |
| Domain | EGF_CA | 3.44e-04 | 99 | 26 | 3 | PS01187 | |
| Domain | - | 3.49e-04 | 20 | 26 | 2 | 4.10.70.10 | |
| Domain | ASX_HYDROXYL | 3.54e-04 | 100 | 26 | 3 | PS00010 | |
| Domain | DISIN | 3.85e-04 | 21 | 26 | 2 | SM00050 | |
| Domain | Disintegrin | 3.85e-04 | 21 | 26 | 2 | PF00200 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 4.20e-04 | 106 | 26 | 3 | IPR000152 | |
| Domain | Keratin_2_head | 5.05e-04 | 24 | 26 | 2 | IPR032444 | |
| Domain | Keratin_2_head | 5.05e-04 | 24 | 26 | 2 | PF16208 | |
| Domain | Keratin_II | 5.93e-04 | 26 | 26 | 2 | IPR003054 | |
| Domain | EGF_CA | 6.33e-04 | 122 | 26 | 3 | SM00179 | |
| Domain | ADAM_Cys-rich | 6.40e-04 | 27 | 26 | 2 | IPR006586 | |
| Domain | ACR | 6.40e-04 | 27 | 26 | 2 | SM00608 | |
| Domain | EGF-like_Ca-bd_dom | 6.64e-04 | 124 | 26 | 3 | IPR001881 | |
| Domain | hEGF | 6.89e-04 | 28 | 26 | 2 | PF12661 | |
| Domain | EGF | 6.96e-04 | 126 | 26 | 3 | PF00008 | |
| Domain | Growth_fac_rcpt_ | 1.29e-03 | 156 | 26 | 3 | IPR009030 | |
| Domain | Peptidase_M12B_N | 1.34e-03 | 39 | 26 | 2 | IPR002870 | |
| Domain | Pep_M12B_propep | 1.34e-03 | 39 | 26 | 2 | PF01562 | |
| Domain | DISINTEGRIN_1 | 1.41e-03 | 40 | 26 | 2 | PS00427 | |
| Domain | ADAM_MEPRO | 1.41e-03 | 40 | 26 | 2 | PS50215 | |
| Domain | DISINTEGRIN_2 | 1.41e-03 | 40 | 26 | 2 | PS50214 | |
| Domain | Reprolysin | 1.41e-03 | 40 | 26 | 2 | PF01421 | |
| Domain | Peptidase_M12B | 1.41e-03 | 40 | 26 | 2 | IPR001590 | |
| Domain | CYSTEINE_SWITCH | 1.48e-03 | 41 | 26 | 2 | PS00546 | |
| Domain | Disintegrin_dom | 1.48e-03 | 41 | 26 | 2 | IPR001762 | |
| Domain | Pept_M10_metallopeptidase | 1.62e-03 | 43 | 26 | 2 | IPR001818 | |
| Domain | Intermediate_filament_CS | 3.45e-03 | 63 | 26 | 2 | IPR018039 | |
| Domain | Filament | 4.37e-03 | 71 | 26 | 2 | SM01391 | |
| Domain | IF | 4.49e-03 | 72 | 26 | 2 | PS00226 | |
| Domain | - | 4.61e-03 | 73 | 26 | 2 | 2.60.120.260 | |
| Domain | Filament | 4.61e-03 | 73 | 26 | 2 | PF00038 | |
| Domain | IF | 4.99e-03 | 76 | 26 | 2 | IPR001664 | |
| Domain | MetalloPept_cat_dom | 5.64e-03 | 81 | 26 | 2 | IPR024079 | |
| Domain | - | 5.64e-03 | 81 | 26 | 2 | 3.40.390.10 | |
| Domain | EGF_CA | 6.34e-03 | 86 | 26 | 2 | PF07645 | |
| Pathway | REACTOME_DEFECTIVE_LFNG_CAUSES_SCDO3 | 1.91e-05 | 5 | 20 | 2 | M27411 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 1.91e-05 | 5 | 20 | 2 | MM14733 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_THE_ENDOPLASMIC_RETICULUM | 2.86e-05 | 6 | 20 | 2 | M27068 | |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | 4.00e-05 | 7 | 20 | 2 | MM14734 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 4.34e-05 | 143 | 20 | 4 | M27275 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_PROTEOLYTIC_ACTIVATION | 1.04e-04 | 11 | 20 | 2 | M47865 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 1.15e-04 | 68 | 20 | 3 | M27303 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380 | 1.25e-04 | 12 | 20 | 2 | M47532 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00381 | 1.25e-04 | 12 | 20 | 2 | M47533 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY | 1.48e-04 | 13 | 20 | 2 | M47423 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00382 | 1.48e-04 | 13 | 20 | 2 | M47534 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 2.89e-04 | 18 | 20 | 2 | M614 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 3.74e-04 | 250 | 20 | 4 | M27554 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 4.75e-04 | 23 | 20 | 2 | MM14954 | |
| Pathway | KEGG_DORSO_VENTRAL_AXIS_FORMATION | 5.18e-04 | 24 | 20 | 2 | M11190 | |
| Pathway | REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 5.63e-04 | 25 | 20 | 2 | M27880 | |
| Pathway | WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES | 5.87e-04 | 118 | 20 | 3 | M39852 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING | 6.57e-04 | 27 | 20 | 2 | M39545 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 7.07e-04 | 28 | 20 | 2 | M6177 | |
| Pathway | WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT | 1.04e-03 | 34 | 20 | 2 | M39390 | |
| Pathway | WP_NEOVASCULARIZATION_PROCESSES | 1.24e-03 | 37 | 20 | 2 | M39506 | |
| Pathway | WP_BREAST_CANCER_PATHWAY | 1.27e-03 | 154 | 20 | 3 | M39739 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 1.37e-03 | 39 | 20 | 2 | MM14604 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 1.45e-03 | 161 | 20 | 3 | M39770 | |
| Pathway | WP_NOTCH_SIGNALING_WP268 | 1.83e-03 | 45 | 20 | 2 | M39571 | |
| Pathway | WP_NOTCH_SIGNALING_PATHWAY | 1.91e-03 | 46 | 20 | 2 | MM15971 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 1.99e-03 | 47 | 20 | 2 | M7946 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 2.16e-03 | 49 | 20 | 2 | M618 | |
| Pathway | PID_NOTCH_PATHWAY | 3.12e-03 | 59 | 20 | 2 | M17 | |
| Pathway | WP_NOTCH_SIGNALING_WP61 | 3.33e-03 | 61 | 20 | 2 | M39540 | |
| Pathway | REACTOME_KERATINIZATION | 3.38e-03 | 217 | 20 | 3 | M27640 | |
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 26634853 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 21191019 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 17881497 | ||
| Pubmed | Notch1 and Notch3 coordinate for pericyte-induced stabilization of vasculature. | 5.37e-07 | 2 | 26 | 2 | 34878922 | |
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 29023469 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 24728738 | ||
| Pubmed | Distinct roles for Notch1 and Notch3 in human adipose-derived stem/stromal cell adipogenesis. | 5.37e-07 | 2 | 26 | 2 | 33021719 | |
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 26563570 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 9665406 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 14595837 | ||
| Pubmed | Nonoverlapping functions for Notch1 and Notch3 during murine steady-state thymic lymphopoiesis. | 5.37e-07 | 2 | 26 | 2 | 21768299 | |
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 25700162 | ||
| Pubmed | Evidence of Notch pathway activation in the ectatic ducts of chronic pancreatitis. | 5.37e-07 | 2 | 26 | 2 | 18069660 | |
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 16507912 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 9402962 | ||
| Pubmed | Overlapping but distinct roles for NOTCH receptors in human cardiovascular disease. | 1.61e-06 | 3 | 26 | 2 | 29767458 | |
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 7698746 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 15987768 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 7615640 | ||
| Pubmed | Notch receptor expression in human brain arteriovenous malformations. | 1.61e-06 | 3 | 26 | 2 | 25846406 | |
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 7918097 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 8645602 | ||
| Pubmed | Notch/CXCR4 Partnership in Acute Lymphoblastic Leukemia Progression. | 1.61e-06 | 3 | 26 | 2 | 31346528 | |
| Pubmed | PD-L1 and Notch as novel biomarkers in pancreatic sarcomatoid carcinoma: a pilot study. | 1.61e-06 | 3 | 26 | 2 | 34846251 | |
| Pubmed | Expression of Notch1 to -4 and their ligands in renal cell carcinoma: a tissue microarray study. | 1.61e-06 | 3 | 26 | 2 | 21471519 | |
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 27840976 | ||
| Pubmed | Smooth muscle Notch1 mediates neointimal formation after vascular injury. | 1.61e-06 | 3 | 26 | 2 | 19433762 | |
| Pubmed | Sequence data and chromosomal localization of human type I and type II hair keratin genes. | 1.61e-06 | 3 | 26 | 2 | 7556444 | |
| Pubmed | Novel KRT83 and KRT86 mutations associated with monilethrix. | 1.61e-06 | 3 | 26 | 2 | 25557232 | |
| Pubmed | Structure and site of expression of a murine type II hair keratin. | 1.61e-06 | 3 | 26 | 2 | 1372089 | |
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 27697639 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 20801121 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 18483410 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 1712823 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 33664344 | ||
| Pubmed | KCTD10 regulates brown adipose tissue thermogenesis and metabolic function via Notch signaling. | 1.61e-06 | 3 | 26 | 2 | 34854382 | |
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 11978185 | ||
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 11459941 | ||
| Pubmed | Prognostic roles of mRNA expression of notch receptors in non-small cell lung cancer. | 3.22e-06 | 4 | 26 | 2 | 28061457 | |
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 21673954 | ||
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 24145721 | ||
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 20069356 | ||
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 9457912 | ||
| Pubmed | Expression and clinical significance of Notch receptors in human renal cell carcinoma. | 3.22e-06 | 4 | 26 | 2 | 19404845 | |
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 28669409 | ||
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 10551863 | ||
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 12391150 | ||
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 11466531 | ||
| Pubmed | Oncogenic activation of the Notch1 gene by deletion of its promoter in Ikaros-deficient T-ALL. | 3.22e-06 | 4 | 26 | 2 | 20829372 | |
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 24151014 | ||
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 20819128 | ||
| Pubmed | Mutational analysis of NOTCH1, 2, 3 and 4 genes in common solid cancers and acute leukemias. | 3.22e-06 | 4 | 26 | 2 | 18184405 | |
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 22705236 | ||
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 15797458 | ||
| Pubmed | Detection of Notch signaling molecules in cemento-ossifying fibroma of the jaws. | 3.22e-06 | 4 | 26 | 2 | 20040020 | |
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 11401408 | ||
| Pubmed | Notch signaling in the mammalian central nervous system: insights from mouse mutants. | 3.22e-06 | 4 | 26 | 2 | 15917835 | |
| Pubmed | Novel MIR143-NOTCH fusions in benign and malignant glomus tumors. | 3.22e-06 | 4 | 26 | 2 | 23999936 | |
| Pubmed | Interplay between Notch1 and Notch3 promotes EMT and tumor initiation in squamous cell carcinoma. | 3.22e-06 | 4 | 26 | 2 | 29170450 | |
| Pubmed | Notch as a mediator of cell fate determination in hematopoiesis: evidence and speculation. | 3.22e-06 | 4 | 26 | 2 | 10194420 | |
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 18156632 | ||
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 23444212 | ||
| Pubmed | Functional conservation of mouse Notch receptor family members. | 3.22e-06 | 4 | 26 | 2 | 8898100 | |
| Pubmed | Assignment of lysosomal alpha-D-mannosidase to mouse chromosome 8. | 3.22e-06 | 4 | 26 | 2 | 8829553 | |
| Pubmed | Deregulated expression of Notch receptors in human hepatocellular carcinoma. | 3.22e-06 | 4 | 26 | 2 | 17920003 | |
| Pubmed | Analysis of HeyL expression in wild-type and Notch pathway mutant mouse embryos. | 3.22e-06 | 4 | 26 | 2 | 11044625 | |
| Pubmed | Notch signaling in bulge stem cells is not required for selection of hair follicle fate. | 5.37e-06 | 5 | 26 | 2 | 19211676 | |
| Pubmed | 5.37e-06 | 5 | 26 | 2 | 15076712 | ||
| Pubmed | Notch3 drives development and progression of cholangiocarcinoma. | 5.37e-06 | 5 | 26 | 2 | 27791012 | |
| Pubmed | 5.37e-06 | 5 | 26 | 2 | 27040987 | ||
| Pubmed | Physical interaction of Delta1, Jagged1, and Jagged2 with Notch1 and Notch3 receptors. | 5.37e-06 | 5 | 26 | 2 | 11006133 | |
| Pubmed | 5.37e-06 | 5 | 26 | 2 | 21124806 | ||
| Pubmed | 5.37e-06 | 5 | 26 | 2 | 12242712 | ||
| Pubmed | 5.37e-06 | 5 | 26 | 2 | 15882997 | ||
| Pubmed | Deficiency of Notch signaling in pericytes results in arteriovenous malformations. | 5.37e-06 | 5 | 26 | 2 | 33148887 | |
| Pubmed | Brain lipid-binding protein is a direct target of Notch signaling in radial glial cells. | 5.37e-06 | 5 | 26 | 2 | 15879553 | |
| Pubmed | Functional diversity of notch family genes in fetal lung development. | 5.37e-06 | 5 | 26 | 2 | 15064243 | |
| Pubmed | A novel tumour-suppressor function for the Notch pathway in myeloid leukaemia. | 5.37e-06 | 5 | 26 | 2 | 21562564 | |
| Pubmed | 5.37e-06 | 5 | 26 | 2 | 23675950 | ||
| Pubmed | 5.37e-06 | 5 | 26 | 2 | 11101851 | ||
| Pubmed | 5.37e-06 | 5 | 26 | 2 | 20554499 | ||
| Pubmed | 8.05e-06 | 6 | 26 | 2 | 9111338 | ||
| Pubmed | Expression of Deltex1 during mouse embryogenesis: comparison with Notch1, 2 and 3 expression. | 8.05e-06 | 6 | 26 | 2 | 11731257 | |
| Pubmed | 8.05e-06 | 6 | 26 | 2 | 20870902 | ||
| Pubmed | 8.05e-06 | 6 | 26 | 2 | 26062937 | ||
| Pubmed | 8.05e-06 | 6 | 26 | 2 | 17822320 | ||
| Pubmed | 8.05e-06 | 6 | 26 | 2 | 11404076 | ||
| Pubmed | Aberrant expression of Notch signaling molecules in patients with immune thrombocytopenic purpura. | 8.05e-06 | 6 | 26 | 2 | 19603167 | |
| Pubmed | 8.05e-06 | 6 | 26 | 2 | 7835890 | ||
| Pubmed | ALDH maintains the stemness of lung adenoma stem cells by suppressing the Notch/CDK2/CCNE pathway. | 8.05e-06 | 6 | 26 | 2 | 24671051 | |
| Pubmed | 8.05e-06 | 6 | 26 | 2 | 18299578 | ||
| Pubmed | Characterization of Notch receptor expression in the developing mammalian heart and liver. | 8.05e-06 | 6 | 26 | 2 | 12244553 | |
| Pubmed | 8.05e-06 | 6 | 26 | 2 | 22526456 | ||
| Pubmed | Loss of the transcription factor RBPJ induces disease-promoting properties in brain pericytes. | 8.05e-06 | 6 | 26 | 2 | 31249304 | |
| Pubmed | 8.05e-06 | 6 | 26 | 2 | 9108364 | ||
| Pubmed | Loss of notch activity in the developing central nervous system leads to increased cell death. | 8.05e-06 | 6 | 26 | 2 | 16508303 | |
| Pubmed | 8.05e-06 | 6 | 26 | 2 | 9882480 | ||
| Pubmed | Cloning and functional characterization of the murine mastermind-like 1 (Maml1) gene. | 8.05e-06 | 6 | 26 | 2 | 15019995 | |
| Pubmed | 8.05e-06 | 6 | 26 | 2 | 19503073 | ||
| Pubmed | Notch controls the magnitude of T helper cell responses by promoting cellular longevity. | 8.05e-06 | 6 | 26 | 2 | 22615412 | |
| Interaction | IGFL3 interactions | 2.11e-06 | 75 | 25 | 4 | int:IGFL3 | |
| Cytoband | 12q13 | 7.48e-04 | 71 | 26 | 2 | 12q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 9.94e-04 | 797 | 26 | 4 | chr19p13 | |
| GeneFamily | Keratins, type II | 4.01e-04 | 27 | 20 | 2 | 609 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 4.01e-04 | 27 | 20 | 2 | 47 | |
| GeneFamily | Ankyrin repeat domain containing | 2.89e-02 | 242 | 20 | 2 | 403 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_DN | 1.88e-05 | 610 | 25 | 6 | M3854 | |
| Coexpression | MARTINEZ_TP53_TARGETS_DN | 1.97e-05 | 615 | 25 | 6 | M8673 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_DN | 2.69e-05 | 650 | 25 | 6 | MM1042 | |
| Coexpression | MARTINEZ_TP53_TARGETS_DN | 2.91e-05 | 659 | 25 | 6 | MM1040 | |
| Coexpression | GSE22935_UNSTIM_VS_12H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_UP | 3.67e-05 | 200 | 25 | 4 | M7758 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 1.04e-04 | 16 | 25 | 2 | M2207 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 1.04e-04 | 16 | 25 | 2 | MM1296 | |
| Coexpression | MOREIRA_RESPONSE_TO_TSA_DN | 1.32e-04 | 18 | 25 | 2 | M3506 | |
| Coexpression | MARTINEZ_RB1_TARGETS_DN | 1.76e-04 | 569 | 25 | 5 | M12701 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2A | 2.25e-04 | 600 | 25 | 5 | M39055 | |
| Coexpression | MARTINEZ_RB1_TARGETS_DN | 2.81e-04 | 630 | 25 | 5 | MM1038 | |
| Coexpression | VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN | 2.83e-04 | 135 | 25 | 3 | M5825 | |
| Coexpression | NABA_MATRISOME | 3.01e-04 | 1008 | 25 | 6 | MM17056 | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_NK-T_NK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.28e-06 | 190 | 26 | 4 | 67fa7472ec534179087963177351552cc3c335eb | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_NK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.28e-06 | 190 | 26 | 4 | 094efcde2b037ae509298abb8b2b1d52f9c86a45 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Nxph3|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 8.01e-06 | 67 | 26 | 3 | b80bdd122a0284611161c40ec7a9c893dc8de4de | |
| ToppCell | facs-Trachea-nan-18m-Mesenchymal-smooth_muscle_cell_of_trachea|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.10e-05 | 151 | 26 | 3 | 5aa98ca9abe37edbc750fd970852a1cc903a5881 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.02e-04 | 157 | 26 | 3 | f2bc60ec0305b056d79f1b7fd6b5e3730d606916 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-mLTo|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.02e-04 | 157 | 26 | 3 | c779a53b2c67d566f5d417e753cd17196a6bfd1c | |
| ToppCell | 367C-Lymphocytic-ILC|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.08e-04 | 160 | 26 | 3 | f70ec054b6d51c1565e4a257cbe3c9537c0eb09f | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4/8-lo|Lung / Manually curated celltypes from each tissue | 1.10e-04 | 161 | 26 | 3 | a1f10e04836848b1deaf295fae033f54d1572fcd | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.12e-04 | 162 | 26 | 3 | 4b9f80f701dcbb2508f497095cb8a7a2ca51cb5e | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.4.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.16e-04 | 164 | 26 | 3 | 8d1d0424943d3e98c8b6399dbf702e0035d0db7b | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW16-Neuronal-GABAergic_neurons|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 1.16e-04 | 164 | 26 | 3 | 4d7b2d0980fb4f47721fa2891151e2bd892ccb91 | |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-MAIT|ICU-SEP / Disease, Lineage and Cell Type | 1.16e-04 | 164 | 26 | 3 | db863a44fc0dad5518c47fdbf64ea21d6f36f089 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_D3|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.25e-04 | 168 | 26 | 3 | 6501495b7ad252af330b18011696c43031541018 | |
| ToppCell | 367C-Lymphocytic-ILC-ILC-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.25e-04 | 168 | 26 | 3 | 80233a13135fd159f5764336a1fe67fba237776b | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.25e-04 | 168 | 26 | 3 | 7abaddbcc55e44653d54aa15464266aa6bd5c9d2 | |
| ToppCell | droplet-Thymus-nan-18m-Myeloid-Macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 169 | 26 | 3 | 4ac21e8199de4b6917eacadc56fffc6d886ee643 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-6_VIP_PENK|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.27e-04 | 169 | 26 | 3 | eb3b8e473192c4b8688f2f8da400116dd6fe193d | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.29e-04 | 170 | 26 | 3 | ce79f5d0d475fcb6c5a61c94938c65210b3c59d9 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4/8-lo|Lung / Manually curated celltypes from each tissue | 1.32e-04 | 171 | 26 | 3 | dfd4a15ab68ef5a9a1954b1b1540ae04017885a6 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.32e-04 | 171 | 26 | 3 | 4fd2c7977c512c51507f055fc74b111c0228ed8b | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 175 | 26 | 3 | c1a8a55af825d5913095f919fa860828df9c273e | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_ductal_cel|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 175 | 26 | 3 | 78b453e220218c84557f244ef7a760e4a1952761 | |
| ToppCell | COPD-Lymphoid-ILC_A|World / Disease state, Lineage and Cell class | 1.41e-04 | 175 | 26 | 3 | e773e330de36f8a0aa9398a176ed7edb5599c582 | |
| ToppCell | COPD-Lymphoid-ILC_A|COPD / Disease state, Lineage and Cell class | 1.43e-04 | 176 | 26 | 3 | 484452cb38fe4604f0910a068361ed461b5b0c21 | |
| ToppCell | metastatic_Brain-Myeloid_cells-CD141+_DCs|metastatic_Brain / Location, Cell class and cell subclass | 1.43e-04 | 176 | 26 | 3 | b9ba7026dee2272c0b483dc0cfa39f74b75f1634 | |
| ToppCell | Dendritic_Cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.46e-04 | 177 | 26 | 3 | d2cd081bdda0eba9f6f6473c4d3939e4bee3440e | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.46e-04 | 177 | 26 | 3 | 507f06d31ab773099c9431b6f433899dc97b5566 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.46e-04 | 177 | 26 | 3 | bde307e67ad8e48a5ff4c0827015f4688f6b3e46 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.46e-04 | 177 | 26 | 3 | 8887ff6341eb070bdaa890cc2cd7745f0cf1b0af | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.51e-04 | 179 | 26 | 3 | c9f45cfea0ceb0cdc31bcfd123aeab69aeb35c35 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_NK-T_NK-ILC_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.51e-04 | 179 | 26 | 3 | bc95c3e7edc5fc6fc913b09f087d221df64c6f48 | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-CD141+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 1.53e-04 | 180 | 26 | 3 | a0b35067b6f2dbd8145da8bab760e9f650f045b0 | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_NK-T_NK-ILC_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.53e-04 | 180 | 26 | 3 | a999a6d219a8e58a8b63802ddf8c95ffaab9cfa0 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-myocytic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.58e-04 | 182 | 26 | 3 | 52274af3136d4fd4a495f5882618444661421f0f | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.58e-04 | 182 | 26 | 3 | dfde2d9950f445c6c936ac828f7210de87bb45ec | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.58e-04 | 182 | 26 | 3 | 9ba85f621a846531a2a7861e9df695d288c9e149 | |
| ToppCell | IPF-Lymphoid-ILC_A|World / Disease state, Lineage and Cell class | 1.58e-04 | 182 | 26 | 3 | f91bb45baaec76cb3bb26eedbcf0709b2492e93f | |
| ToppCell | Dendritic_Cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 1.61e-04 | 183 | 26 | 3 | 499da89b4abe7b746e703cd1e5c56f9b1d97ac3c | |
| ToppCell | IPF-Lymphoid-ILC_A|IPF / Disease state, Lineage and Cell class | 1.61e-04 | 183 | 26 | 3 | 49bfeaae13eb236f61a5486ee75c39789936bb8a | |
| ToppCell | T_cells-Resident_memory_CD8+_T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.63e-04 | 184 | 26 | 3 | e04cabff33a8e36967622ec3e5b37b89afa7e148 | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 1.66e-04 | 185 | 26 | 3 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Hematopoietic-T_cells-NK_cell|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.69e-04 | 186 | 26 | 3 | 885aed2472cead81d60c9f3a28c0ff10eb449592 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.69e-04 | 186 | 26 | 3 | 0096a61b1841784c913752b4f3639200446cc02c | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_NK-T_NK-CD56_bright_NK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.69e-04 | 186 | 26 | 3 | e0eeef2b9e06324354c5a11a4c6d4c98546f32af | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.69e-04 | 186 | 26 | 3 | 9e159ad7289dcae2ec7ce655df746f46801b81d3 | |
| ToppCell | wk_08-11-Hematologic_Lymphocytic-NK-CD56bright_NK|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.69e-04 | 186 | 26 | 3 | 7b67e588b3c95074367b2cf20d2fc72d1385ee28 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-T_cells-ILCP|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.69e-04 | 186 | 26 | 3 | 428b4cbee3d3ab666cab2fc2d9c815318359e458 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.69e-04 | 186 | 26 | 3 | 6345777847960c71a2ba3ce5a49c72c34ebd0e73 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.71e-04 | 187 | 26 | 3 | 43ef900b76f3c38bd8ce9858201124130c743d56 | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_D3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.71e-04 | 187 | 26 | 3 | c667fae6440dc98072b584f203d00f0fb1cb2f21 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.71e-04 | 187 | 26 | 3 | 387cb27c8a20031cd87381a9e1172f1f62e1488b | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Epithelial-Epithelial,_Airway-secretory_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.71e-04 | 187 | 26 | 3 | 6e5c38425b6b1d4774f8dcea7e146f1eab785c3e | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_D3|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.74e-04 | 188 | 26 | 3 | ecc2364d946f97ae0212fd6739960c9fc75e4919 | |
| ToppCell | tumor_Lung-Myeloid_cells-CD141+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 1.74e-04 | 188 | 26 | 3 | 9874ba56bf6a0d509cccc89563dbf1395e17e84e | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.77e-04 | 189 | 26 | 3 | f75cebd4c3e54e297557449ba67ccc8d1a2a14f5 | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_NK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.77e-04 | 189 | 26 | 3 | 723c57f278919e8251d56b3d19411f9088319450 | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_NK-T_NK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.77e-04 | 189 | 26 | 3 | 960374f5fb278659500a7c948c3068a95dd62eb0 | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-NK-CD56bright_NK|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.79e-04 | 190 | 26 | 3 | c8031df82c3662ce4140c850277987f7210e9bcd | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Dendritic-conventional_dendritic_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.82e-04 | 191 | 26 | 3 | f814dc20034bafa1c0e8dfe98e58370cf3f73bee | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Dendritic-conventional_dendritic_cell-DC1_(conventional_dendritic_cell)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.82e-04 | 191 | 26 | 3 | 1155c28407ff97d950d70d53256a9fb6307a2bac | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Dendritic-conventional_dendritic_cell-DC1_(conventional_dendritic_cell)-DC1_L.1.2.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.82e-04 | 191 | 26 | 3 | 8947010e47218095c5032f24c41e245e7977a33d | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 1.82e-04 | 191 | 26 | 3 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c07-AHNAK|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.82e-04 | 191 | 26 | 3 | b53b490a8796e819edd3eb4a5a42b4499077b2d3 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c04-ANXA2|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.82e-04 | 191 | 26 | 3 | 9c747f8cc1cdce45e839b661d782e1e8cfb79578 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-NK|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.85e-04 | 192 | 26 | 3 | 930319cbd82b9e54864147ffcdc8bd0ea7b937be | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-NK-NK|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.85e-04 | 192 | 26 | 3 | c7bcebcb88a25b2c97d798120efa9d5958e7f798 | |
| ToppCell | Healthy_donor-CD4+_Tcm|World / disease group, cell group and cell class (v2) | 1.85e-04 | 192 | 26 | 3 | 1603903454ba6bf65c8e13ede620e0b1e8fbd7ec | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-DC-DC3-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.88e-04 | 193 | 26 | 3 | 5a4accf3af236ff285942163c45277a80263f421 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.88e-04 | 193 | 26 | 3 | 000b9e6a819b94ea2e6e9173daf97ba9ac2b6cc6 | |
| ToppCell | Healthy/Control-CD4+_Tcm|Healthy/Control / Disease group and Cell class | 1.91e-04 | 194 | 26 | 3 | 08b25c41566d071e079e492cb2c33015b80da72d | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_NK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.91e-04 | 194 | 26 | 3 | 5afe7f48d3383f3dac18765f97999c8b6936dc1b | |
| ToppCell | Healthy/Control-CD4+_Tcm|World / Disease group and Cell class | 1.91e-04 | 194 | 26 | 3 | cbdd1786305108cbeddea07a21120067d78c59a0 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.91e-04 | 194 | 26 | 3 | 67f5e2f05a8de2213ab80d5ea16fdee121684633 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_NK-T_NK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.91e-04 | 194 | 26 | 3 | ec7e0ca6c9a2f63938e06ee771da09eff14fc3b5 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-DC-DC3|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.94e-04 | 195 | 26 | 3 | de60fa0c69c835f0b1d6d2dba1a1acd73246b001 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-T_cells|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.94e-04 | 195 | 26 | 3 | d81ac3a8f2b7b767bdd03641ab6329917273cd75 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Dendritic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.97e-04 | 196 | 26 | 3 | 787088ce800d7148bad7265a971797da597b029a | |
| ToppCell | Control-Lymphocyte-T_NK-NK_CD56bright|Control / Disease, Lineage and Cell Type | 1.97e-04 | 196 | 26 | 3 | c0ebef067aa333c7a18c697031b0417b3335b75c | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.97e-04 | 196 | 26 | 3 | 9c942bf9fc78caa173d2c7de5fe4c17f076c623b | |
| ToppCell | 367C-Lymphocytic-NK_cells|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.97e-04 | 196 | 26 | 3 | c6fac4ead13834483e780188de7d417e5cf37611 | |
| ToppCell | COVID-19-kidney-T-cells-1|kidney / Disease (COVID-19 only), tissue and cell type | 2.00e-04 | 197 | 26 | 3 | 9bb7faf4ef63cca4d06c60e6c05a9616fdb6b98e | |
| ToppCell | Biopsy_Control_(H.)-Immune-B_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 2.00e-04 | 197 | 26 | 3 | c78e0cf394b9a4e10ebba61f6392d9b5a23db9d8 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Lymphocytic-NK-ILC-T_NK-ILC|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.00e-04 | 197 | 26 | 3 | 9791923feefbd78810242113ad2a08ce4c2bb4f2 | |
| ToppCell | VE-NK|VE / Condition, Cell_class and T cell subcluster | 2.00e-04 | 197 | 26 | 3 | cae6ff8763501e7a5897b50188ac2640d65a47c0 | |
| ToppCell | mLN-T_cell-Th1|T_cell / Region, Cell class and subclass | 2.00e-04 | 197 | 26 | 3 | 5e39a49dddef04469ff2b615d755ddf6a926e58e | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Macroglial|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.00e-04 | 197 | 26 | 3 | 965d5a3f8c9b12cb8a8d3429702ae29ebd8c6122 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Macroglial-Astroglia|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.00e-04 | 197 | 26 | 3 | 3f088eb29197bc575400d6dafd8083e69e4a149f | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell-DC2_(CD1c+_dendritic_cell)-DC2_L.1.2.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.00e-04 | 197 | 26 | 3 | 515a2d0ee2bd3fc0a5a0c315e2b0c752e6af7406 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell-DC2_(CD1c+_dendritic_cell)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.00e-04 | 197 | 26 | 3 | 4fccdc69ab4b966de6465f06677435e6f6e6abcd | |
| ToppCell | VE-NK-|VE / Condition, Cell_class and T cell subcluster | 2.00e-04 | 197 | 26 | 3 | ee89b8521fb4faaed9e4d39f7171e45eccf38b00 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.00e-04 | 197 | 26 | 3 | bfa04e5f4156a01df4217b1f59676edb0a7563e1 | |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-T-T_CD8-gdT|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.03e-04 | 198 | 26 | 3 | 9dc91a1101eef649a301f0147ecd5c028a9c2b12 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Suprabasal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.03e-04 | 198 | 26 | 3 | 19d8ff3a4f911b13ecc34844202925475ad4d2ab | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c02-AQP3|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.03e-04 | 198 | 26 | 3 | d24e3c9bafd6df52eefcca5e8dcd493f72c2583a | |
| ToppCell | 390C-Lymphocytic-NK_cells|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.03e-04 | 198 | 26 | 3 | 623e5ada1a54cd42c32a1519b84dbe782384ee0c | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4-Teffector/EM_CD4|Lung / Manually curated celltypes from each tissue | 2.06e-04 | 199 | 26 | 3 | 54b6a43e23826d507b8f1db578e589711d49bbfd | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-cDC1|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.06e-04 | 199 | 26 | 3 | c6da5c517dbcfa621fa6dda9e0c1985ba2f3bbdb | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.06e-04 | 199 | 26 | 3 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-cDC1-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.06e-04 | 199 | 26 | 3 | b9613e88c4b752529d6ae20857744418207b0830 | |
| ToppCell | Sepsis-ICU-SEP-Lymphocyte-T/NK-MAIT|ICU-SEP / Disease, condition lineage and cell class | 2.06e-04 | 199 | 26 | 3 | 2f10622319c6146dfed8cfe3844180c1e1d56e94 | |
| Disease | hair disease (is_implicated_in) | 5.81e-07 | 2 | 23 | 2 | DOID:421 (is_implicated_in) | |
| Disease | MONILETHRIX | 1.74e-06 | 3 | 23 | 2 | 158000 | |
| Disease | monilethrix (is_implicated_in) | 1.74e-06 | 3 | 23 | 2 | DOID:0050472 (is_implicated_in) | |
| Disease | Beaded hair | 1.74e-06 | 3 | 23 | 2 | cv:C0546966 | |
| Disease | Monilethrix | 3.48e-06 | 4 | 23 | 2 | C0546966 | |
| Disease | central nervous system cancer (implicated_via_orthology) | 1.22e-05 | 7 | 23 | 2 | DOID:3620 (implicated_via_orthology) | |
| Disease | adenocarcinoma (implicated_via_orthology) | 1.22e-05 | 7 | 23 | 2 | DOID:299 (implicated_via_orthology) | |
| Disease | Carcinoma, Pancreatic Ductal | 1.59e-04 | 24 | 23 | 2 | C0887833 | |
| Disease | brain cancer (implicated_via_orthology) | 1.87e-04 | 26 | 23 | 2 | DOID:1319 (implicated_via_orthology) | |
| Disease | colorectal cancer (implicated_via_orthology) | 2.49e-04 | 30 | 23 | 2 | DOID:9256 (implicated_via_orthology) | |
| Disease | intestinal cancer (implicated_via_orthology) | 2.84e-04 | 32 | 23 | 2 | DOID:10155 (implicated_via_orthology) | |
| Disease | inflammatory bowel disease | 3.72e-04 | 449 | 23 | 4 | EFO_0003767 | |
| Disease | clinical treatment | 4.68e-04 | 41 | 23 | 2 | EFO_0007056 | |
| Disease | Skin Neoplasms | 9.68e-04 | 59 | 23 | 2 | C0037286 | |
| Disease | Malignant neoplasm of skin | 9.68e-04 | 59 | 23 | 2 | C0007114 | |
| Disease | Glioblastoma | 1.73e-03 | 79 | 23 | 2 | C0017636 | |
| Disease | Parkinson disease | 1.92e-03 | 321 | 23 | 3 | MONDO_0005180 | |
| Disease | Giant Cell Glioblastoma | 1.95e-03 | 84 | 23 | 2 | C0334588 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ASGGCYVTSLCRCFG | 481 | P54793 | |
| CEGGQAYCYNGMCLT | 506 | Q9H013 | |
| CFCRMCAVFGGIYCL | 386 | P24386 | |
| MCYGYGCGCGSFCRL | 1 | Q3LHN2 | |
| GTCKDMTSGYVCTCR | 766 | P46531 | |
| MTSGYVCTCREGFSG | 771 | P46531 | |
| MTCYRGFLLGSCCRV | 1 | Q4G0N4 | |
| MTCGSYCGGRAFSCI | 1 | O43790 | |
| CFGSHGDQCMSCKYG | 696 | Q92824 | |
| MGYCSGRCTLIFICG | 1 | Q5VXU1 | |
| GQFTCICMAGFTGTY | 451 | Q9UM47 | |
| AYGTACCGGFCGVRE | 736 | Q9Y5I4 | |
| CIMGSGRTGFSNCSY | 361 | Q9UKF2 | |
| MGAYARASGVCARGC | 1 | O00754 | |
| AMGSAYGSCTCLGAQ | 36 | Q8N813 | |
| CACAGMIYLGYTFCG | 421 | Q8IZK6 | |
| RMRCYNCGGSPSSSC | 21 | O95868 | |
| MATEFIKSCCGGCFY | 1 | Q8N9U0 | |
| SCLYGTCCLRGMTYS | 161 | Q6ZMB5 | |
| GTCNANGTMYGCSCD | 1021 | O14594 | |
| SAGCRGGCFTYTMSR | 206 | Q03519 | |
| CMVCTVCGDCTGYGA | 766 | O75592 | |
| TKCSATCGGGHYMRT | 851 | Q13591 | |
| ASGCDLMCCGRGYNT | 301 | O00755 | |
| SCESGTCGEIFMGYS | 36 | Q8N8L2 | |
| LVCLCSGLGASFCYM | 151 | Q5BJD5 | |
| IVSMACCASGSTRGY | 646 | P35573 | |
| MTCGSGFGGRAFSCI | 1 | Q14533 |